Published 1 month ago

FDA Forced to Retract Misleading Statements on Ivermectin's COVID-19 Use After Legal Challenge

Summary by Ground News

The FDA has settled a lawsuit brought by three doctors, agreeing to delete and never republish several social media posts suggesting that ivermectin is for animals and not humans. The lawsuit, filed by doctors Mary Talley Bowden, Paul Marik, and Robert Apter, claimed the FDA was interfering with their ability to practice medicine. The settlement marks a significant development in the ongoing debate over the drug's use.

0 Articles

All

Left

Center

Right

Austin County News Online

FDA Forced to Retract Misleading Statements on Ivermectin's COVID-19 Use After Legal Challenge

The FDA has been compelled to retract several social media posts that misleadingly suggested ivermectin, a drug used by some doctors to treat COVID-19, is solely for animals. This comes after a lawsuit brought by three doctors accusing the agency of interfering with their medical practice. The settlement highlights ongoing debates over ivermectin's use and the FDA's communication strategies.

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 month agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

FDA Forced to Retract Misleading Statements on Ivermectin's COVID-19 Use After Legal Challenge

0 Articles

0 Articles

FDA Forced to Retract Misleading Statements on Ivermectin's COVID-19 Use After Legal Challenge

FDA Forced to Retract Misleading Statements on Ivermectin's COVID-19 Use After Legal Challenge

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics